Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 23, 2009, 6:04PM ET - U.S. Markets Closed. Dow  0.01% Nasdaq  0.75%

Cephalon Inc. (CEPH)

At 4:00PM ET: 59.83   0.11 (0.18%)

MORE ON CEPH

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Nov 2, 2009 • CEO Interview, Cortex Pharmaceuticals, Inc. - Dr. Mark Varney Wall Street Transcript (Mon, Nov 2) • Biotech Calendar: Key Dates for November at TheStreet.com (Mon, Nov 2) Sat, Oct 31, 2009 • CEPHALON INC Financials EDGAR Online Financials (Sat, Oct 31) • [$$] Going to Extremes at Barrons.com (Sat, Oct 31) Fri, Oct 30, 2009 • Covidien gets approval for generic pain drug Actiq AP (Fri, Oct 30) Thu, Oct 29, 2009 • Trading Review for Jazz Pharmaceuticals Inc. Issued by Beacon Equity GlobeNewswire (Thu, Oct 29) Wed, Oct 28, 2009 • CEPHALON INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Oct 28) Tue, Oct 27, 2009 • Cephalon Q3 2009 Earnings Call Transcript at Seeking Alpha (Tue, Oct 27) • Biotech firm Cephalon 3Q profit falls 2.7 percent AP (Tue, Oct 27) • Cephalon, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN (Tue, Oct 27) • CEPHALON INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online (Tue, Oct 27) • Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009 PR Newswire (Tue, Oct 27) • Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations PR Newswire (Tue, Oct 27) • Q3 2009 Cephalon, Inc. Earnings Release - 4:10 pm ET CCBN (Tue, Oct 27) Mon, Oct 26, 2009 • Cephalon signs buyout option deal with BioAssets AP (Mon, Oct 26) • Cephalon close to buying BioAssets, developer of sciatica treatment at bizjournals.com (Mon, Oct 26) • Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation PR Newswire (Mon, Oct 26) Fri, Oct 23, 2009 • Don't Miss This Cheap Stock at Motley Fool (Fri, Oct 23) Thu, Oct 22, 2009 • 'Fast Money' Recap: Bullish on Amazon at TheStreet.com (Thu, Oct 22) • Your First Move For Friday October 23rd at CNBC (Thu, Oct 22) • CEPHALON INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Thu, Oct 22) • Unusual Call Activity in Cephalon: Options at TheStreet.com (Thu, Oct 22) Wed, Oct 21, 2009 • Teva seeking to sell generic version of Cephalon’s Nuvigil sleep disorder drug at bizjournals.com (Wed, Oct 21) • Cephalon Notified of Generic Filing for Armodafinil Tablets PR Newswire (Wed, Oct 21) Tue, Oct 20, 2009 • BioDelivery Sciences International, Inc. - Mark A. Sirgo Wall Street Transcript (Tue, Oct 20) Older Headlines - Most Recent Headlines View headlines from: Tue, Oct 20, 2009Tue, Oct 13, 2009Tue, Oct 6, 2009Tue, Sep 29, 2009Tue, Sep 22, 2009Tue, Sep 15, 2009Tue, Sep 8, 2009Tue, Sep 1, 2009Tue, Aug 25, 2009Tue, Aug 18, 2009 Add CEPH News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage